Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2169/internalmedicine.9576-17 http://scihub22266oqcxt.onion/10.2169/internalmedicine.9576-17 C5919858!5919858 !29269661     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29269661 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Intern+Med 2018 ; 57 (7 ): 987-991 Nephropedia Template TP {{tp|p=29269661 |t=2018. Pazopanib-induced Endothelial Injury with Podocyte Changes |pdf=|usr=}}{{29269661 }} gab.com Text Pazopanib-induced Endothelial Injury with Podocyte Changes JO: Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=29269661 #FOAvip Pazopanib has been reported to induce proteinuria; however, no pathological findings have been reported. We herein report the case of a 31-year-old man with rhabdomyosarcoma treated with pazopanib who developed nephrotic syndrome. A renal biopsy revealed endothelial injury with podocyte changes. Based on the biopsy findings, we diagnosed the patient with nephrotic syndrome caused by pazopanib. Following the discontinuation of pazopanib, the patient's proteinuria gradually decreased without any specific treatment. We should be careful when encountering drug-induced proteinuria in patients taking pazopanib. Twit Text FOAVip Pazopanib-induced Endothelial Injury with Podocyte Changes ????Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=29269661 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29269661 #FOAvip English Wikipedia <ref>{{Cite pmid|29269661 }}</ref> Pazopanib-induced Endothelial Injury with Podocyte Changes #MMPMID29269661 Maruyama K ; Nakagawa N ; Suzuki A ; Kabara M ; Matsuki M ; Shindo M ; Ogawa Y ; Hasebe N Intern Med 2018[Apr]; 57 (7 ): 987-991 PMID29269661 show ga Pazopanib has been reported to induce proteinuria; however, no pathological findings have been reported. We herein report the case of a 31-year-old man with rhabdomyosarcoma treated with pazopanib who developed nephrotic syndrome. A renal biopsy revealed endothelial injury with podocyte changes. Based on the biopsy findings, we diagnosed the patient with nephrotic syndrome caused by pazopanib. Following the discontinuation of pazopanib, the patient's proteinuria gradually decreased without any specific treatment. We should be careful when encountering drug-induced proteinuria in patients taking pazopanib. |Adult [MESH] |Humans [MESH] |Indazoles [MESH] |Male [MESH] |Nephrotic Syndrome/*chemically induced/*diagnostic imaging/pathology/therapy [MESH] |Podocytes/pathology [MESH] |Proteinuria/*chemically induced/therapy [MESH] |Pyrimidines/*adverse effects/*therapeutic use [MESH] |Receptors, Vascular Endothelial Growth Factor/*therapeutic use [MESH] |Rhabdomyosarcoma/*drug therapy [MESH]Pazopanib-induced Endothelial Injury with Podocyte Changes (epmc).pdf DeepDyve Pubget Overpricing